Latest Healthcare News

Page 2 of 197
Actinogen Medical’s shares have been suspended while it completes analysis of additional data from its pivotal XanaMIA Alzheimer’s trial. The company expects trading to resume no later than 19 November unless the results announcement comes first.
Ada Torres
Ada Torres
17 Nov 2026
Regis Healthcare delivered higher revenue, earnings and cash generation in FY26, but its new CEO is confronting a sharp funding gap across the aged care sector. The company plans to offset weaker AN-ACC support through pricing, cost reductions and further expansion.
Ada Torres
Ada Torres
17 Nov 2026
Mayne Pharma has agreed to a A$6.40-a-share cash takeover by Hungary’s Gedeon Richter, valuing the company’s equity at approximately A$604 million. The recommended scheme still depends on regulatory clearances, shareholder and court approval, and completion of Mayne’s international business sale.
Victor Sage
Victor Sage
17 Nov 2026
Marlin Global outperformed its benchmark in October as financial, healthcare and consumer holdings offset sharp falls in Alphabet and Meta. The Fisher Funds-managed portfolio recorded a 0.1% gross return while adjusted NAV slipped 0.1%.
Claire Turing
Claire Turing
17 Nov 2026
Barramundi’s portfolio outperformed its benchmark in October, but two holdings each fell 46% after company-specific setbacks. The NZX-listed investment company also added Wesfarmers as its one new position during the month.
Victor Sage
Victor Sage
17 Nov 2026
Moderna’s chief legal officer will retire in March under an agreement that provides US$1.63 million in fixed severance and up to US$8 million linked to litigation outcomes. The package also preserves her salary, benefits and equity vesting through her departure date.
Ada Torres
Ada Torres
14 Nov 2026
Revvity has set out a long-range growth strategy built around AI-enabled scientific discovery, recurring software revenue and specialised diagnostics. The plan includes double-digit adjusted EPS growth, margin expansion and about US$5 billion of capital capacity through 2031, but formal 2027 guidance is still pending.
Ada Torres
Ada Torres
14 Nov 2026
BCAL Diagnostics, an 18.46% shareholder of Genetic Signatures, has asked the Takeovers Panel to intervene over the proposed merger with Microba Life Sciences. The application alleges the deal structure and shareholder process lack adequate protections, although no Panel has yet been appointed and no decision has been made.
Ada Torres
Ada Torres
13 Nov 2026
Genetic Signatures’ proposed Microba merger faces a formal challenge from 18.46% shareholder BCAL Diagnostics, which alleges the process lacks adequate protections and information for GSS investors. The Takeovers Panel has not yet appointed a sitting Panel or decided whether to open proceedings.
Ada Torres
Ada Torres
13 Nov 2026
Mach7 Technologies has signed Temple Health to a five-year licence for its eUnity Viewer and Vendor Neutral Archive, with Year 1 annual recurring revenue expected to reach A$0.5 million. The revenue will depend on go-live and first productive use, forecast within six to 12 months.
Victor Sage
Victor Sage
13 Nov 2026
Artrya has signed its first inbound US customer outside its foundation and research relationships, securing a five-year HonorHealth agreement with a minimum value of US$0.5 million. The Salix platform will be deployed across the Arizona health system’s nine-hospital CCTA network.
Victor Sage
Victor Sage
13 Nov 2026
Ramsay Santé has secured approval for a foreign exempt listing on the ASX, clearing a key operational hurdle for Ramsay Health Care’s proposed demerger. The transaction remains conditional on shareholder, Court and other approvals, with CDI trading provisionally scheduled to begin from 1 December.
Ada Torres
Ada Torres
12 Nov 2026

Browse the archive

Full archive